EMPIRICAL THERAPY IN MANAGEMENT OF PNEUMONIA WITH MULTI-DRUG RESISTANT RISK FACTORS: A RETROSPECTIVE ANALYSIS COMPARING VANCOMYCIN PLUS PIPERACILLIN/TAZOBACTAM VERSUS VANCOMYCIN PLUS CEFEPIME